Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant

Suzuki R^#, Yamasoba D^#, Kimura I^#, Wang L^#, Kishimoto M^#, Ito J^# (#equal contribution) Morioka Y, Nao N, Nasser H, Uriu K, Kosugi Y, Tsuda M, Orba Y, Sasaki M, Shimizu R, Kawabata R, Yoshimatsu K, Asakura H, Nagashima M, Sadamasu K, Yoshimura K, The Genotype to Phenotype Japan (G2P-Japan) Consortium, Sawa H, Ikeda T, Irie T, Matsuno K*, Tanaka S*, Fukuhara T*, Sato K* (*equal correspondence). Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant. Nature. 603, 700-705, 2022.